Form 4 Filing: Appajosyula Sireesh Buys $100K of $HEPA

INSIDER PURCHASE

⚡ MATERIALITY: 6/10

corporate issuer

Hepion Pharmaceuticals, Inc.

Ticker: $HEPA

Transaction Value

$100K

Price/Share: $0.05

transaction date

2026-08-03

Shares: 2,000,000

Market Price Activity

HillSignal AI Analytical Report

SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Appajosyula Sireesh, holds the title of Chief Operating Officer at Hepion Pharmaceuticals, Inc..

On 2026-08-03, the insider transacted 2,000,000 shares.The shares were transacted at a weighted average price of $0.05 per share, resulting in a total market-relevant value of $100K.

Executive Summary Summary

Appajosyula Sireesh (Chief Operating Officer) bought $100K of $HEPA

Post-Transaction Position: 3,250,000 shares

SEC Accession No: 0001493152-26-037490 (CIK: 1901565)

Verified Multi-Source Index

Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.

SEC EDGAR FilingView Source Form 4

Yahoo Finance$HEPA Quote & Profile

OpenCorporates RegistryVerify Corporate Identity

Google News$HEPA News Coverage